MedPath

A randomized controlled trial which aim at establishment of standard diagnosis and treatment for colonic diverticular bleeding

Not Applicable
Recruiting
Conditions
Colonic diverticular bleeding
Registration Number
JPRN-UMIN000026865
Lead Sponsor
ational Hospital Organization Tokyo Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
240
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients with hemorrhagic shock accompanying severe disturbance of consciousness at the time of visit. 2)Patients who do not improve from hemorrhagic shock even after infusion or transfusion. 3)Patients with confirmed melena. 4)Patients who have renal insufficiency and are determined to be inappropriate for use of contrast medium. 5)Patients taking antidiabetes drug of biguanide type. 6)Patients who are diagnosed as inflammatory bowel disease. 7)Patients with suspected hemorrhoidal bleeding. 8)Patients with performance status of grade2 or more. 9)Patients with contrast medium allergies. 10)Patients who are pregnant, or who are possibly pregnant. 11)Patients who have participated in this study in the past. 12)Patients who the principal investigator or other investigators decided not suitable for participation in this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Identification rate of colonic diverticular bleeding points.
Secondary Outcome Measures
NameTimeMethod
Success rate of endoscopic hemostasis, time from last hematochezia to hemostasis, hemostatic rate classified by time from last hematochezia to colonoscopy, completion rate of colonoscopy, observed rate of extravasation of contrast medium on CT, hospitalization period, re-bleeding rate, additional colonoscopy rate and consequential hemostasis rate, rate of interventional radiology treatment required and consequential hemostasis rate, additional surgery rate and consequential hemostasis rate, incidence rate of adverse event, final diagnosis for cause of hematochezia.
© Copyright 2025. All Rights Reserved by MedPath